Children's Specialized Hospital Programs and Services
The Largest Global Clinical Research Program in Autism, Asperger’s Disorder and Pervasive Development Disorder Not Otherwise Specified Now Enrolling at Children’s Specialized Hospital
ConnectMe clinical research program is evaluating the safety, tolerability and effectiveness of an investigational drug on social interaction and communication in children with autism spectrum disorders
December 05, 2012 - Children's Specialized Hospital

Children’s Specialized Hospital in Toms River, NJ, announced today that they are taking part in the largest-ever global clinical research program in children ages 6 to 12 with autism, Asperger’s Disorder, and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). This Phase II ConnectMe clinical research program, which is currently enrolling participants in the Toms River area, is evaluating the safety, tolerability, and efficacy of the investigational drug, memantine, on social interaction and communication. There are currently no FDA-approved drugs that treat any of the three core symptoms of autism — impaired social interactions; impaired communication; and, restricted interests, repetitive behaviors and stereotyped mannerisms.
 
The ConnectMe clinical research program is being led locally by Yvette Janvier, MD, and her team at Children’s Specialized Hospital. “Problems with socialization and communication can have a devastating impact on families touched by autism spectrum disorders, which makes the ConnectMe clinical research program one of the most insightful research endeavors to date, in addition to being the largest global program,” says Dr. Janvier, Toms River Medical Director, Children’s Specialized Hospital. “Children’s Specialized Hospital is known for our research in the area of autism, so we are incredibly excited to be a part of the ConnectMe clinical research program.”
 
According to the Centers for Disease Control and Prevention, these autism spectrum disorders affect one out of every 88 children in the US. Two of the most common characteristics of these disorders are problems with social interaction and communication.
 
About The ConnectMe Clinical Research Program
The ConnectMe clinical research protocols were developed by Forest Research Institute, Inc., under the guidance of the United States Food and Drug Administration (FDA). The investigational drug in the ConnectMe clinical research program contains the active ingredient memantine hydrochloride, in dosage strengths unique to pediatric patients. To learn more about the ConnectMe clinical research program in the United States or to see if your child is eligible to participate in one of the 85+ sites across the country, visit www.connectmetrial.com or call 1 (877) 900-8735.
 
About Children’s Specialized Hospital
Children’s Specialized Hospital is the preeminent provider of rehabilitation services for children with special needs. The hospital serves children affected by brain injury, spinal cord injury, premature birth, autism, developmental delays, and life-changing illnesses. Children’s Specialized Hospital has nine sites in New Jersey and treats 19,000 children each year, making it the largest pediatric rehabilitation system of its kind in the nation. Services include outpatient services, acute rehabilitation, and long-term care through its sites in Bayonne, Clifton, Egg Harbor Township, Mountainside, Toms River, Fanwood, Hamilton, New Brunswick and Roselle Park as well as outreach programs in many communities. Children's Specialized Hospital is a proud member of the Children's Miracle Network Hospitals. Children’s Specialized Hospital Foundation supports the programs and services of the hospital. The Foundation is ranked among the top six pediatric hospital foundations in the country. To help, or find more information: visit www.childrens-specialized.org; join us on www.facebook.com/childrensspecialized, or follow us on Twitter @ChildrensSpecNJ.
 
Related Links
Contact Us
Children's Specialized Hospital Foundation
908-301-5561
Follow us on:  

Sign up for our email list!